Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$115,292,819
+$41,039,787 QoQ
Shares Held
96,123
+19.1% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
1.02%
of 13F equity value
Holder Rank
#355
of 4,605 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EP Wealth Advisors, LLC holds $468,870,808 across 14 Drug Manufacturers - General names. LLY ranks #2 (24.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
708,767 | $180,005,554 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
96,123 | $115,292,819 | |
| 3 | ABBV |
AbbVie Inc.
|
297,328 | $74,819,617 | |
| 4 | MRK |
Merck & Co., Inc.
|
282,377 | $36,285,444 | |
| 5 | AMGN |
Amgen Inc
|
70,291 | $25,453,776 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
113,192 | $14,300,677 | |
| 7 | NVS |
Novartis AG
|
38,592 | $6,048,138 | |
| 8 | PFE |
Pfizer Inc
|
247,206 | $5,952,720 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $115,292,819 | 96,123 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $74,253,032 | 80,730 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $80,899,768 | 75,278 | Shares | Sole | 2026-02-18 | |
| 2025-06-30 | $55,960,120 | 71,787 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $57,106,721 | 69,144 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $26,199,364 | 33,937 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $29,973,122 | 33,832 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $28,361,933 | 31,326 | Shares | Sole | 2024-08-19 | |
| 2024-03-31 | $24,269,240 | 31,196 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $20,493,135 | 35,156 | Shares | Sole | 2024-02-28 | |
| 2023-09-30 | $14,047,023 | 26,152 | Shares | Sole | 2023-11-24 | |
| 2023-06-30 | $3,038,521 | 6,479 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $20,703 | 25,025 | Shares | Sole | 2023-06-05 | |
| 2022-12-31 | $9,361,845 | 25,590 | Shares | Sole | 2023-06-12 | |
| 2022-09-30 | $8,070,816 | 24,960 | Shares | Sole | 2022-12-02 | |
| 2022-06-30 | $2,116,573 | 6,528 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,867,418 | 6,521 | Shares | Sole | 2022-05-20 | |
| 2021-12-31 | $1,797,639 | 6,508 | Shares | Sole | 2022-02-17 | |
| 2021-09-30 | $1,411,715 | 6,110 | Shares | Sole | 2021-11-23 | |
| 2021-06-30 | $1,740,220 | 7,582 | Shares | Sole | 2021-08-24 | |
| 2021-03-31 | $1,529,308 | 8,186 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,297,366 | 7,684 | Shares | Sole | 2021-02-18 | |
| 2020-09-30 | $845,342 | 5,711 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $906,000 | 0 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $965,768 | 6,962 | Shares | Sole | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||